Table 1

Demographics and baseline characteristics before and after propensity-score matching

Preoperative characteristicsBefore matchingAfter matching
Total
(n=40 527)
Spinal (n=9847)General (n=30 680)P valueTotal
(n=14 716)
Spinal (n=7358)General (n=7358)P value
Age (years), mean (SD)80.25 (9.73)81.79 (8.93)79.76 (9.93)<0.00181.32 (9.16)81.25 (9.14)81.40 (9.17)0.30
Sex, female (n)68.84% (27 897)71.23% (7014)68.07% (20 883)<0.00171.15% (10 471)71.23% (5241)71.08% (5230)0.84
BMI (kg/m2), mean (SD)25.23 (5.84)24.53 (5.39)25.41 (5.95)<0.00124.59 (5.39)24.58 (5.39)24.59 (5.38)0.90
ASA class<0.0010.99
 I0.60% (242)0.83% (82)0.52% (160)0.74% (109)0.75% (55)0.73% (54)
 II15.23% (6173)16.72% (1646)14.76% (4527)18.06% (2657)17.97% (1322)18.14% (1335)
 III62.43% (25 300)59.45% (5854)63.38% (19 446)60.21% (8861)60.06% (4419)60.37% (4442)
 IV21.42% (8679)22.47% (2213)21.08% (6466)20.66% (3041)20.90% (1538)20.43% (1503)
 V0.18% (71)0.19% (19)0.17% (52)0.20% (29)0.19% (14)0.20% (15)
 None assigned0.15% (62)0.34% (33)0.09% (29)0.13% (19)0.14% (10)0.12% (9)
Diabetes (n)18.56% (7520)16.12% (1587)19.34% (5933)<0.00116.06% (2364)16.53% (1216)15.60% (1148)0.13
Smoker (n)11.53% (4673)10.40% (1024)11.89% (3649)<0.00110.78% (1586)10.99% (809)10.56% (777)0.39
COPD (n)10.50% (4256)10.82% (1065)10.40% (3191)0.2411.35% (1670)11.44% (842)11.25% (828)0.72
Congestive heart failure (n)3.71% (1505)3.21% (316)3.88% (1189)0.0023.13% (460)3.19% (235)3.06% (225)0.64
Hypertension (n)66.48% (26 944)62.67% (6171)67.71% (20 773)<0.00163.20% (9300)63.37% (4663)63.02% (4637)0.66
Acute renal failure (n)0.58% (236)0.37% (36)0.65% (200)0.0010.33% (48)0.31% (23)0.34% (25)0.77
Current dialysis (n)1.93% (784)1.23% (121)2.16% (663)<0.0011.37% (201)1.30% (96)1.43% (105)0.52
Disseminated cancer (n)3.32% (1347)2.72% (268)3.52% (1079)<0.0012.87% (423)2.83% (208)2.92% (215)0.73
Open wound (with or without infection) (n)3.67% (1487)2.37% (233)4.09% (1254)<0.0012.36% (347)2.36% (174)2.35% (173)0.96
Steroid use (n)5.63% (2283)4.94% (486)5.86% (1797)<0.0014.98% (733)5.07% (373)4.89% (360)0.62
Bleeding disorder (n)17.10% (6929)8.00% (788)20.02% (6141)<0.0017.72% (1136)7.76% (571)7.68% (565)0.85
Emergent case (n)31.69% (12 844)49.51% (4875)25.97% (7969)<0.00145.04% (6628)44.86% (3301)45.22% (3327)0.67
Functional status<0.0010.96
 Independent (n)77.58% (31 441)77.66% (7647)77.56% (23 794)79.06% (11 635)79.23% (5830)78.89% (5805)
 Partially dependent (n)18.86% (7644)18.23% (1795)19.06% (5849)17.85% (2627)17.72% (1304)17.98% (1323)
 Totally dependent (n)3.02% (1223)3.32% (327)2.92% (896)2.57% (378)2.54% (187)2.60% (191)
 Unknown (n)0.54% (219)0.79% (78)0.46% (141)0.52% (76)0.50% (37)0.53% (39)
Dementia (n)28.63% (11 603)30.80% (3033)27.93% (8570)<0.00128.50% (4194)28.20% (2075)28.80% (2119)0.42
Preoperative delirium (n)12.81% (5146)12.56% (1228)12.88% (3918)0.4011.20% (1648)11.13% (819)11.27% (829)0.79
Fracture type<0.0010.028
 Femoral neck—undisplaced8.45% (3425)8.09% (797)8.57% (2628)8.52% (1254)7.95% (585)9.09% (669)
 Femoral neck—displaced29.45% (11 937)31.78% (3129)28.71% (8808)31.50% (4636)32.36% (2381)30.65% (2255)
 Intertrochanteric53.85% (21 823)52.14% (5134)54.40% (16 689)51.90% (7638)51.52% (3791)52.28% (3847)
 Unknown2.04% (828)1.68% (165)2.16% (663)1.95% (287)1.86% (137)2.04% (150)
 Subtrochanteric6.20% (2514)6.32% (622)6.17% (1892)6.12% (901)6.31% (464)5.94% (437)
  • a: alpha level set at 0.05.

  • ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease.